Anand Kiran Parikh
Chief Operating Officer at Faeth Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 7 months
- Director since
- 2026
7 months of board service in total across 1 board, counting each seat separately. Longest: Faeth Therapeutics Inc., 7 months.
Faeth Therapeutics Inc.
Director · President and CEO
Chief executive roles
Faeth Therapeutics Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | Faeth Therapeutics Inc. | Open-market purchase | +2,806 | $19.76 | $55,447 |
| Jun 22, 2026 | Faeth Therapeutics Inc. | Option exercise | +45,252 | $1.16 | $52,492 |
| Jun 22, 2026 | Faeth Therapeutics Inc. | Option exercise | +8,213 | $1.16 | $9,527 |
| Jun 15, 2026 | Faeth Therapeutics Inc. | Derivative conversion | +761,428 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.